Ignite Creation Date:
2024-05-06 @ 1:52 AM
Last Modification Date:
2024-10-26 @ 11:11 AM
Study NCT ID:
NCT01925573
Status:
TERMINATED
Last Update Posted:
2022-02-03
First Post:
2013-08-13
Brief Title:
OptuneNOVOTTF-100A Bevacizumab Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma GCC 1344
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-13
First Submit QC Date:
August 16 2013
Study First Post Date:
2013-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-02-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-05
Last Update Post Date:
2022-02-03
Last Update Post Date Type:
ACTUAL